In the diagnosis of prostate cancer, PSMA-targeted PET imaging is an emerging method of prostate cancer imaging; its sensitivity and specificity are better than those of traditional imaging to a certain extent, and it greatly improves the detection rate of early prostate cancer (Chen et al. 2016). This evidence concerns the gene FOLH1 and Familial prostate cancer.